# A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures

> **NCT05610085** · PHASE2 · RECRUITING · sponsor: **University of California, San Diego** · enrollment: 133 (estimated)

## Conditions studied

- Neonatal Seizure
- Neonatal Encephalopathy
- Hypoxic-Ischemic Encephalopathy
- Seizure Newborn

## Interventions

- **DRUG:** Levetiracetam Injection
- **DRUG:** Phenobarbital Sodium Injection

## Key facts

- **NCT ID:** NCT05610085
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-24
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-12-31
- **Target enrollment:** 133 (ESTIMATED)
- **Last updated:** 2025-10-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05610085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05610085, "A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05610085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*